Who is sponsoring NCT03406052?

NCT03406052 is sponsored by York University.

What drugs are being tested in NCT03406052?

Interventions in NCT03406052: Smartphone-Assisted MB-CBT.

What condition does NCT03406052 study?

NCT03406052 studies Disorder, Major Depressive.

Is NCT03406052 still recruiting?

NCT03406052 is currently suspended. Last updated 23 April 2019.

Last reviewed 2019-04-23 · How we verify

NCT03406052

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Smartphone-enabled Health Coaching Intervention for Youth Diagnosed With Major Depressive Disorders

Suspended NA Last updated 23 April 2019

What this trial tests

NA trial testing Smartphone-Assisted MB-CBT in Disorder, Major Depressive in 168 participants. Suspended.

Timeline

19 January 2018

Primary endpoint
31 March 2019

30 May 2019

Quick facts

Lead sponsor	York University
Phase	NA
Status	Suspended
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	supportive care
Enrollment	168
Start date	19 January 2018
Primary completion	31 March 2019
Estimated completion	30 May 2019
Sites	1 location across Canada

Drugs / interventions tested

Smartphone-Assisted MB-CBT

Conditions studied

Disorder, Major Depressive — all drugs for Disorder, Major Depressive →

Sponsor

York University

Who can join

Adults 18 to 30, any sex, with Disorder, Major Depressive. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomized controlled trial (RCT) comparing youth diagnosed with major depressive disorder treated with online mindfulness-based cognitive behavioural therapy vs. standard psychiatric care (as wait-list controls). Eligible subjects will be recruited from the wait-lists of the Centre for Addiction and Mental Health. N = 168 subjects will consist of youth from First Nations background (18-30 yrs) and youth from all other ethnic backgrounds stratified to two intervention groups and two wait-list control groups consisting of 50% First Nations youth and 50% youth of all other ethnic backgrounds.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Online Mindfulness-Based Cognitive Behavioral Therapy Intervention for Youth With Major Depressive Disorders: Randomized Controlled Trial.
Ritvo P, Knyahnytska Y, Pirbaglou M, Wang W, et al · · 2021 · cited 29× · PMID 33688840 · DOI 10.2196/24380
The Role of Daily Steps in the Treatment of Major Depressive Disorder: Secondary Analysis of a Randomized Controlled Trial of a 6-Month Internet-Based, Mindfulness-Based Cognitive Behavioral Therapy Intervention for Youth.
Dang K, Ritvo P, Katz J, Gratzer D, et al · · 2023 · cited 8× · PMID 38064262 · DOI 10.2196/46419
The Use of Text Messaging as an Adjunct to Internet-Based Cognitive Behavioral Therapy for Major Depressive Disorder in Youth: Secondary Analysis.
Walters C, Gratzer D, Dang K, Laposa J, et al · · 2024 · cited 1× · PMID 38820586 · DOI 10.2196/40275

Verify or expand the search:

Other York University trials

Trials by the same sponsor.

NCT07513987 — IMPACT: Immune and Musculoskeletal Physiological Adaptations to Combined Exercise Training & Nutrition · NA · not yet recruiting
NCT07312409 — Does Taurine Supplementation Improve Vascular Function and Orthostatic Responses in Long COVID? · NA · not yet recruiting
NCT07418320 — Grow Together, Thrive Together: A Feasibility Study of a Brief Relationship Intervention for Emerging Adults and Their C · NA · not yet recruiting
NCT07351630 — Building Blocks for Child and Family Well-being · NA · recruiting
NCT06458933 — Testing Interventions for Borderline Personality Disorder. · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03406052 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by York University
Last refreshed: 23 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03406052.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing